Company intelligence / Profile preview
Xiamen Origin Biotech
Xiamen, Fujian, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Xiamen Origin Biotech is a clinical-stage biopharmaceutical company based in China, specializing in the development of next-generation cell therapies for cancer. The company focuses on Chimeric Antigen Receptor T-cell (CAR-T) therapies, with a particular emphasis on "off-the-shelf" Universal CAR-T (UCAR-T) technologies designed to overcome the limitations of autologous treatments. Their pipeline includes candidates targeting hematological malignancies and solid tumors, such as hepatocellular carcinoma. By leveraging advanced gene editing and cell engineering, Xiamen Origin Biotech aims to provide more accessible and effective immunotherapy options for patients globally.
- Therapeutic areas
- Oncology
- Modalities
- Cell therapyCAR-T cell therapyUniversal CAR-T cell therapy
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Xiamen Origin Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xiamen Origin Biotech.